1.Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1): 7–30.
2.Hikami S, Shiozaki A, Fujiwara H, Konishi H,Arita T, Kosuga T, Morimura R, Murayama Y, Komatsu S, Ikoma H, et al. Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal Cancer Gan To Kagaku Ryoho. 2017; 44(12):1796–1798.
3.Saddoughi SA, Reinersman JM,; Zhukov YO, Taswell J, Mara K, Harmsen SW,
Blackmon SH, Cassivi SD, Nichols F, Shen KR, et al. Survival After Surgical Resection of Stage IV Esophageal Cancer. Ann Thorac Surg. 2017; 103 (1): 261–6.
4.Zhang Y, Xue W, Li X, Zhang J, Chen S, Zhang JL, Yang L, Chen LL. The Biogenesis of Nascent Circular RNAs. Cell Rep. 2016; 15 (3): 611–24.
5.Liang D, Wilusz JE. Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 2014; 28(20): 2233–47.
6.Greene J, Baird AM, Brady L,Lim M, Gray SG. Biogenesis, Function and Role in Human Diseases. Front Mol Biosci. 2017; 4: 38.
7.Beermann J, Piccoli MT, Viereck J,et al.. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016; 96(4): 1297–325.
8.Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 25(1):1–7.
9.Meng S, Zhou H, Feng Z,Xu Z, Tang Y, Li P, Wu M. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 16(1): 94.
10.Guo XY, He CX, Wang YQ, un C, Li GM, Su Q, Pan Q, Fan JG. Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis. Biomed Res Int. 2017; 2017: 5936171.
11.Miao R, Wang Y, Wan J, Leng D, Gong J, Li J, Liang Y, Zhai Z, Yang Y. Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension. Medicine (Baltimore). 2017;. 96(27): e7354.
12.Ren S, Xin Z, Xu Y,Xu J, Wang G. Construction and analysis of circular RNA molecular regulatory networks In liver cancer. Cell Cycle. 2017; 16(22):2204–2211.
13.Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, Tang W, Cao H. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017; 8(42):73271–73281.
14.Huang S, Yang B, Chen BJ, Bliim N, Ueberham U, Arendt T, Janitz M.
The emerging role of circular RNAs in transcriptome regulation. Genomics. 2017; 109(5–6):401–407.
15.Liang HF, Zhang XZ, Liu BG, Jia GT, Li WL. Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR–1271. Am J Cancer Res. 2017; 7(7): 1566–76.
16.Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L, Chen J. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 2017; 403: 305–17.
17.Zhang H, Wang G, Ding C,Liu P, Wang R, Ding W, Tong D, Wu D, Li C, Wei Q, et al. Increased circular RNA UBAP2 acts as a sponge of miR–143 to promote osteosarcoma progression. Oncotarget. 2017; 8(37):61687–61697.
18.Liu YC, Li JR, Sun CH, Andrews E, Chao RF, Lin FM, Weng SL, Hsu SD, Huang CC, Cheng C, et al. CircNet: a database of circular RNAs derived from transcriptome sequencing data. Nucleic Acids Res. 2016; 44(D1): D209–15.
19.Ghosal S, Das S, Sen R, Basak P, Chakrabarti J. Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits. Front Genet. 2013; 4: 283.
20.Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol. 2003; 5(1): R1.
21.PasquinelliAE, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012; 13(4): 271–82.
22.Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1): W460–6.
23.Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF;Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013; 19(2): 141–57.
24.Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976; 73(11): 3852–6.
25.Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013; 495(7441): 333–8.
26.Huang YS, Jie N, Zou KJ,Weng Y. Expression profile of circular RNAs in human: astric cancer tissues. MolMed Rep. 2017; 16(3): 2469–76.
27.Huang G, Li S, Yang N, Zou Y, Zheng D, Xiao T. Recent progress in circular RNAs in human cancers. Cancer Lett. 2017; 404: 8–18.
28.Kumar L, Shamsuzzama, Haque R, Baghel T, Nazir A. Circular RNAs: the Emerging Class of Non-coding RNAs and Their Potential Role in Human Neurodegenerative Diseases. Mol Neurobiol. 2017; 54(9):7224–7234.
29.Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 2010; 6(12): e1001233.
30.Zhang XO, Wang HB, Zhang Y, Chen L,Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014; 159(1): 134–47.
31.Li Z, Huang C, Bao C,Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015; 22(3): 256–64.
32.Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M Corrigendum. Global quantification of mammalian gene expression control. Nature. 2013; 495(7439): 126–7.
33.Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441): 384–8.
34.Hansen TB, Wiklund ED, Bramsen JB,Villadsen SB, Statham AL, Clark SJ, Kjems J. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. Embo j. 2011; 30(21): 4414–22.
35.Peng L, Yuan XQ, Li GC. The emerging landscape of circular RNA ciRS–7 in cancer (Review). Oncol Rep. 2015; 33(6): 2669–74.
36.Pan H, Li T, Jiang Y, Pan C, Ding Y, Huang Z, Yu H, Kong D. Overexpression of Circular RNA ciRS–7 Abrogates the Tumor Suppressive Effect of miR–7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway. J Cell Biochem. 2018; 119(1):440–446.
37.Zhao Y, Alexandrov PN, Jaber V, Lukiw WJ. Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA–7 Sponge (circRNA; ciRS–7). Genes (Basel). 2016; 7(12).:pii: E116.
- Teresa Requena, Sonia Cabrera, Carmen Martín-Sierra, Steven D, Price Anna Lysakowski, José A. Lopez-Escamez. Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere’s disease ,Hum Mol Genet. 2015; 24(4):1119–26.
- Zlotina A, Nikulina T, Yany N, Moiseeva O, Pervunina T, Grekhov E, Kostareva A. Ring chromosome 18 in combination with 18q12.1 (DTNA) interstitial microdeletion in a patient with multiple congenital defects. Mol Cytogenet. 2016; 9:18.
- Wang L, Zhu MJ, Ren AM, Wu HF, Han WM, Tan RY, Tu RQ. A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer.PLoS One. 2014; 9(5):e96472.
- Tang J, Zhuo H, Zhang X, Jiang R, Ji J, Deng L, Qian X, Zhang F, Sun B. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation anmetastasis in hepatocellular carcinoma.Cell Death Dis. 2014; 5:e1549.
- Habib Motieghader, Morteza Kouhsar, Balal Sadeghi, Ali Masoudi-Nejad.. mRNA–miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Mol Biosyst. 2017; 13(10):2168–2180..
- Le Tao, Yigang Zeng, Jun Wang, Zhihong Liu, Bing Shen, Jifu Ge, Yong Liu, Yifeng Guo, Jiangxin Qiu. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Mol Med Rep. 2015; 12(5): 6533–6546.
44.Anandaram H. A computational approach to identify microRNA (miRNA) based biomarker from the regulation of disease pathology. Biol Med Case Rep. 2018; 2: 12–25.
45.Fujiwara T, Yada T. miRNA-target prediction based on transcriptional regulation. BMC Genomics. 2013; 14 Suppl 2: S3.
46.Liu B, Li J, Cairns MJ. Identifying miRNAs, targets and functions. Brief Bioinform. 2014; 15(1):1–19.
47.Guo L, Zhao Y, Yang S, Zhang H, Chen F.. Integrative analysis of miRNA-mRNA and miRNA-miRNA interactions. Biomed Res Int. 2014; 2014: 907420.
48.Bindea G, Galon J, Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013; 29(5): 661–3.
49. Ibrahim Malami, Ahmad Bustamam Abdul, Rasedee Abdullah,Nur Kartinee Bt Kassim, Peter Waziri, Imaobong Christopher Etti. Imaobong Christopher Etti . In silico discovery of potential Uridine-Cytidine Kinase 2 inhibitors from the Rhizome of Alpiniamutica. Molecules 2016; 21(4):417
50.Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol. 2009; 35(1):109–14.
- Zhong-Ming Lu, Ye-Feng Lin, Li Jiang, Liang-Si Chen, Xiao-Ning Luo, Xin-Han Song, Shao-Hua Chen, Si-Yi Zhang. Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma. Onco Targets Ther. 2014; 7: 525–533.
- Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR;Smith MJ, Regan M, McAnena OJ, Kerin MJ. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis.2011; 26(11):1415–22.
53 Jin C, Yan B, Lu Q, Ma L. Reciprocal regulation of Hsa-miR–1 and long noncoding RNA MALAT1 promotes triple-negativebreast cancer development.Tumour Biol. 2016, 37(6):7383–94